Results 151 to 160 of about 3,518,988 (354)
Understanding and interpreting confidence and credible intervals around effect estimates.
L. Hespanhol +3 more
semanticscholar +1 more source
Inhibition of Classical and Alternative Complement Pathway by Ravulizumab and Eculizumab
ABSTRACT Objective To explore the feasibility of classical (CH50) and alternative (AH50) complement pathway activity as potential biomarkers for treatment guidance and monitoring during therapy with ravulizumab in patients with generalized myasthenia gravis (gMG) and compare these to therapeutic drug monitoring under eculizumab.
Lea Gerischer +14 more
wiley +1 more source
A New Approach to the Nonparametric Behrens-Fisher Problem With Compatible Confidence Intervals. [PDF]
Schüürhuis S +2 more
europepmc +1 more source
Simultaneous confidence intervals for an extended Koch-Röhmel design in three-arm non-inferiority trials. [PDF]
Scharpenberg M, Brannath W.
europepmc +1 more source
Changes in Immune‐Inflammation Status and Acute Ischemic Stroke Prognosis in Prospective Cohort
ABSTRACT Background Inflammation is a critical risk factor for poor outcomes in cerebral infarction. Prior studies focused primarily on baseline inflammation status, neglecting dynamic longitudinal changes. We try to investigate the association between immune‐inflammation status alterations and stroke prognosis, and evaluated three systemic biomarkers'
Songfang Chen +11 more
wiley +1 more source
Informative simultaneous confidence intervals for graphical test procedures. [PDF]
Brannath W, Kluge L, Scharpenberg M.
europepmc +1 more source
Decision curve analysis: confidence intervals and hypothesis testing for net benefit. [PDF]
Vickers AJ +3 more
europepmc +1 more source
Advantages of Monte Carlo Confidence Intervals for Indirect Effects
Kristopher J Preacher, J. Selig
semanticscholar +1 more source

